Medtronic Plc Stock Current Valuation

MDT Stock

USD 90.33 0.89 0.98%

Valuation analysis of Medtronic PLC helps investors to measure Medtronic PLC's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to gain to about 187.9 B in 2025, whereas Enterprise Value Over EBITDA is likely to drop 12.54 in 2025. Fundamental drivers impacting Medtronic PLC's valuation include:

Price Book

2.3458

Enterprise Value

134.5 B

Enterprise Value Ebitda

15.5462

Price Sales

3.4896

Forward PE

15.456

Undervalued

Today

90.33

Please note that Medtronic PLC's price fluctuation is very steady at this time. Calculation of the real value of Medtronic PLC is based on 3 months time horizon. Increasing Medtronic PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.

Buy or Sell Advice Valuation Matrix

Medtronic PLC's intrinsic value may or may not be the same as its current market price of 90.33, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.

Historical

Market 90.33

Real 100.12

Target 95.56

Hype 90.39

Naive 86.44

The intrinsic value of Medtronic PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medtronic PLC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.

81.30

Downside

100.12

Real Value

Target Odds

Above Odds

Below Odds

101.69

Upside

Estimating the potential upside or downside of Medtronic PLC helps investors to forecast how Medtronic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medtronic PLC more accurately as focusing exclusively on Medtronic PLC's fundamentals will not take into account other important factors:

Earnings

Estimates (0)

Low	Projected	High
1.36	1.58	1.37

Details

Hype

Prediction

Low	Estimated	High
88.82	90.39	91.96

Details

Potential

Annual Dividend

Low	Forecasted	High
2.00	2.08	2.15

Details

32 Analysts

Consensus

Low	Target Price	High
86.96	95.56	106.07

Details

Medtronic PLC Company Current Valuation Analysis

Medtronic PLC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Medtronic PLC Current Valuation

134.54 B

Most of Medtronic PLC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Medtronic Current Valuation Driver Correlations

Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Current Valuation. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Long Term Debt	Good Will	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.99	0.97	0.78	0.9	0.99	0.89	0.24	0.88	0.88	0.89	0.98	0.38	-0.97	0.84	0.42	-0.71	-0.86	0.16	0.49	-0.69	-0.61	-0.53	-0.48	0.17
Total Stockholder Equity	0.99		0.94	0.74	0.89	0.96	0.86	0.18	0.84	0.92	0.86	0.99	0.31	-0.98	0.88	0.32	-0.78	-0.89	0.22	0.39	-0.77	-0.69	-0.6	-0.55	0.2
Net Debt	0.97	0.94		0.84	0.9	0.99	0.89	0.26	0.87	0.82	0.88	0.93	0.45	-0.91	0.82	0.55	-0.56	-0.8	0.15	0.58	-0.56	-0.51	-0.47	-0.45	0.02
Retained Earnings	0.78	0.74	0.84		0.77	0.82	0.8	0.02	0.77	0.58	0.8	0.71	0.6	-0.68	0.6	0.62	-0.29	-0.69	-0.01	0.7	-0.21	-0.18	-0.21	-0.2	-0.1
Net Receivables	0.9	0.89	0.9	0.77		0.88	0.91	0.12	0.69	0.83	0.77	0.86	0.47	-0.8	0.82	0.28	-0.59	-0.74	0.21	0.33	-0.57	-0.57	-0.56	-0.53	0.07
Total Liab	0.99	0.96	0.99	0.82	0.88		0.9	0.3	0.92	0.81	0.91	0.95	0.45	-0.94	0.78	0.54	-0.61	-0.82	0.08	0.6	-0.59	-0.5	-0.43	-0.38	0.13
Total Current Assets	0.89	0.86	0.89	0.8	0.91	0.9		0.24	0.76	0.72	0.82	0.81	0.72	-0.78	0.69	0.43	-0.49	-0.65	0.06	0.5	-0.46	-0.4	-0.37	-0.32	0.05
Short Term Debt	0.24	0.18	0.26	0.02	0.12	0.3	0.24		0.29	0.02	0.18	0.13	0.13	-0.19	-0.06	0.47	0.06	0.2	-0.23	0.35	-0.15	0.08	0.2	0.27	-0.28
Intangible Assets	0.88	0.84	0.87	0.77	0.69	0.92	0.76	0.29		0.59	0.91	0.83	0.42	-0.88	0.53	0.68	-0.48	-0.76	-0.21	0.78	-0.43	-0.24	-0.18	-0.09	0.25
Accounts Payable	0.88	0.92	0.82	0.58	0.83	0.81	0.72	0.02	0.59		0.67	0.94	0.12	-0.88	0.98	0.04	-0.86	-0.86	0.51	0.07	-0.86	-0.89	-0.79	-0.8	0.14
Long Term Debt	0.89	0.86	0.88	0.8	0.77	0.91	0.82	0.18	0.91	0.67		0.84	0.54	-0.88	0.63	0.58	-0.58	-0.8	-0.09	0.67	-0.41	-0.32	-0.17	-0.23	0.3
Good Will	0.98	0.99	0.93	0.71	0.86	0.95	0.81	0.13	0.83	0.94	0.84		0.24	-0.98	0.9	0.29	-0.8	-0.92	0.26	0.36	-0.79	-0.72	-0.64	-0.59	0.22
Short Term Investments	0.38	0.31	0.45	0.6	0.47	0.45	0.72	0.13	0.42	0.12	0.54	0.24		-0.25	0.11	0.51	0.05	-0.13	-0.25	0.57	0.17	0.21	0.22	0.18	-0.09
Common Stock	-0.97	-0.98	-0.91	-0.68	-0.8	-0.94	-0.78	-0.19	-0.88	-0.88	-0.88	-0.98	-0.25		-0.82	-0.35	0.8	0.91	-0.15	-0.43	0.76	0.65	0.52	0.49	-0.3
Property Plant Equipment	0.84	0.88	0.82	0.6	0.82	0.78	0.69	-0.06	0.53	0.98	0.63	0.9	0.11	-0.82		0.03	-0.79	-0.84	0.55	0.05	-0.78	-0.87	-0.8	-0.84	0.08
Current Deferred Revenue	0.42	0.32	0.55	0.62	0.28	0.54	0.43	0.47	0.68	0.04	0.58	0.29	0.51	-0.35	0.03		0.21	-0.17	-0.45	0.95	0.21	0.37	0.38	0.36	-0.23
Long Term Investments	-0.71	-0.78	-0.56	-0.29	-0.59	-0.61	-0.49	0.06	-0.48	-0.86	-0.58	-0.8	0.05	0.8	-0.79	0.21		0.79	-0.41	0.13	0.9	0.86	0.67	0.68	-0.46
Short Long Term Debt	-0.86	-0.89	-0.8	-0.69	-0.74	-0.82	-0.65	0.2	-0.76	-0.86	-0.8	-0.92	-0.13	0.91	-0.84	-0.17	0.79		-0.24	-0.32	0.67	0.66	0.59	0.6	-0.4
Net Tangible Assets	0.16	0.22	0.15	-0.01	0.21	0.08	0.06	-0.23	-0.21	0.51	-0.09	0.26	-0.25	-0.15	0.55	-0.45	-0.41	-0.24		-0.5	-0.48	-0.68	-0.71	-0.8	-0.26
Deferred Long Term Liab	0.49	0.39	0.58	0.7	0.33	0.6	0.5	0.35	0.78	0.07	0.67	0.36	0.57	-0.43	0.05	0.95	0.13	-0.32	-0.5		0.18	0.35	0.35	0.37	-0.07
Long Term Debt Total	-0.69	-0.77	-0.56	-0.21	-0.57	-0.59	-0.46	-0.15	-0.43	-0.86	-0.41	-0.79	0.17	0.76	-0.78	0.21	0.9	0.67	-0.48	0.18		0.92	0.81	0.7	-0.2
Capital Surpluse	-0.61	-0.69	-0.51	-0.18	-0.57	-0.5	-0.4	0.08	-0.24	-0.89	-0.32	-0.72	0.21	0.65	-0.87	0.37	0.86	0.66	-0.68	0.35	0.92		0.91	0.88	-0.14
Net Invested Capital	-0.53	-0.6	-0.47	-0.21	-0.56	-0.43	-0.37	0.2	-0.18	-0.79	-0.17	-0.64	0.22	0.52	-0.8	0.38	0.67	0.59	-0.71	0.35	0.81	0.91		0.85	0.02
Cash And Equivalents	-0.48	-0.55	-0.45	-0.2	-0.53	-0.38	-0.32	0.27	-0.09	-0.8	-0.23	-0.59	0.18	0.49	-0.84	0.36	0.68	0.6	-0.8	0.37	0.7	0.88	0.85		-0.01
Net Working Capital	0.17	0.2	0.02	-0.1	0.07	0.13	0.05	-0.28	0.25	0.14	0.3	0.22	-0.09	-0.3	0.08	-0.23	-0.46	-0.4	-0.26	-0.07	-0.2	-0.14	0.02	-0.01

Click cells to compare fundamentals

Medtronic Current Valuation Historical Pattern

Today, most investors in Medtronic PLC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medtronic PLC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Medtronic PLC current valuation as a starting point in their analysis.

Medtronic PLC Current Valuation

Timeline

Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Competition

Predict Medtronic PLC

Enterprise Value Over Time

In accordance with the recently published financial statements, Medtronic PLC has a Current Valuation of 134.54 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is significantly lower than that of the firm.

Medtronic Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.

Medtronic PLC is currently under evaluation in current valuation category among its peers.

Medtronic PLC ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.

Environmental

Governance

Social

Medtronic Fundamentals

	Return On Equity	0.0844
	Return On Asset	0.0466
	Profit Margin	0.13 %
	Operating Margin	0.22 %
	Current Valuation	134.54 B
	Shares Outstanding	1.28 B
	Shares Owned By Insiders	0.26 %
	Shares Owned By Institutions	86.21 %
	Number Of Shares Shorted	13.49 M
	Price To Earning	20.44 X
	Price To Book	2.35 X
	Price To Sales	3.49 X
	Revenue	32.36 B
	Gross Profit	21.78 B
	EBITDA	8.2 B
	Net Income	3.68 B
	Cash And Equivalents	1.54 B
	Cash Per Share	8.59 X
	Total Debt	26.05 B
	Debt To Equity	0.51 %
	Current Ratio	1.76 X
	Book Value Per Share	38.48 X
	Cash Flow From Operations	6.79 B
	Short Ratio	1.94 X
	Earnings Per Share	3.28 X
	Price To Earnings To Growth	1.55 X
	Target Price	97.05
	Number Of Employees	95 K
	Beta	0.82
	Market Capitalization	115.85 B
	Total Asset	89.98 B
	Retained Earnings	30.4 B
	Working Capital	11.15 B
	Current Asset	23.6 B
	Current Liabilities	7.17 B
	Annual Yield	0.03 %
	Five Year Return	2.18 %
	Net Asset	89.98 B
	Last Dividend Paid	2.79

About Medtronic PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Plc Stock Current Valuation

Medtronic PLC Company Current Valuation Analysis

Enterprise Value

Market Cap + Debt

-

Cash

Current Medtronic PLC Current Valuation

Medtronic Current Valuation Driver Correlations

Medtronic Current Valuation Historical Pattern

Medtronic Current Valuation Peer Comparison

Medtronic PLC ESG Sustainability

Medtronic Fundamentals

About Medtronic PLC Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Medtronic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY